Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 20394957)

1.

Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.

Gupta M, Goldsmith CS, Metcalfe MG, Spiropoulou CF, Rollin PE.

Virology. 2010 Jun 20;402(1):203-8. doi: 10.1016/j.virol.2010.03.024. Epub 2010 Apr 14. Erratum in: Virology. 2010 Oct 10;406(1):165. Spipopoulou, Christina F [corrected to Spiropoulou, Christina F].

2.

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.

Towner JS, Sealy TK, Khristova ML, Albariño CG, Conlan S, Reeder SA, Quan PL, Lipkin WI, Downing R, Tappero JW, Okware S, Lutwama J, Bakamutumaho B, Kayiwa J, Comer JA, Rollin PE, Ksiazek TG, Nichol ST.

PLoS Pathog. 2008 Nov;4(11):e1000212. doi: 10.1371/journal.ppat.1000212. Epub 2008 Nov 21.

3.

Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.

Gupta M, MacNeil A, Reed ZD, Rollin PE, Spiropoulou CF.

Virology. 2012 Feb 20;423(2):119-24. doi: 10.1016/j.virol.2011.11.027. Epub 2011 Dec 23.

4.

Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008.

Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, Amone J, Mbabazi W, Nanyunja M, Zaramba S, Opio A, Lutwama JJ, Talisuna AO, Okware SI.

Emerg Infect Dis. 2010 Jul;16(7):1087-92. doi: 10.3201/eid1607.091525.

5.

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e837. doi: 10.1371/journal.pntd.0000837.

6.

Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.

MacNeil A, Farnon EC, Wamala J, Okware S, Cannon DL, Reed Z, Towner JS, Tappero JW, Lutwama J, Downing R, Nichol ST, Ksiazek TG, Rollin PE.

Emerg Infect Dis. 2010 Dec;16(12):1969-72. doi: 10.3201/eid1612.100627.

7.

Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype).

Hutchinson KL, Villinger F, Miranda ME, Ksiazek TG, Peters CJ, Rollin PE.

J Med Virol. 2001 Nov;65(3):561-6.

PMID:
11596094
9.

Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.

Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala J, Yoti Z, Colebunders R, Palma PP, Sterk E, Jeffs B, Van Herp M, Borchert M.

PLoS One. 2012;7(12):e52986. doi: 10.1371/journal.pone.0052986. Epub 2012 Dec 28.

10.

Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.

Gupta M, Spiropoulou C, Rollin PE.

Virology. 2007 Jul 20;364(1):45-54. Epub 2007 Mar 27.

11.

Case fatality rates of Ebola virus diseases: a meta-analysis of World Health Organization data.

Lefebvre A, Fiet C, Belpois-Duchamp C, Tiv M, Astruc K, Aho Glélé LS.

Med Mal Infect. 2014 Sep;44(9):412-6. doi: 10.1016/j.medmal.2014.08.005. Epub 2014 Sep 2.

PMID:
25193630
12.

Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston).

Morikawa S, Saijo M, Kurane I.

Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):391-8. Epub 2007 Jul 3. Review.

PMID:
17610952
13.

Cytokine and chemokine expression in humans infected with Sudan Ebola virus.

Hutchinson KL, Rollin PE.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S357-63.

14.

Filovirus outbreak detection and surveillance: lessons from Bundibugyo.

MacNeil A, Farnon EC, Morgan OW, Gould P, Boehmer TK, Blaney DD, Wiersma P, Tappero JW, Nichol ST, Ksiazek TG, Rollin PE.

J Infect Dis. 2011 Nov;204 Suppl 3:S761-7. doi: 10.1093/infdis/jir294.

15.

Immunopathogenesis of severe acute respiratory disease in Zaire ebolavirus-infected pigs.

Nfon CK, Leung A, Smith G, Embury-Hyatt C, Kobinger G, Weingartl HM.

PLoS One. 2013 Apr 23;8(4):e61904. doi: 10.1371/journal.pone.0061904. Print 2013.

16.

Cathepsin B & L are not required for ebola virus replication.

Marzi A, Reinheckel T, Feldmann H.

PLoS Negl Trop Dis. 2012;6(12):e1923. doi: 10.1371/journal.pntd.0001923. Epub 2012 Dec 6.

17.

Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.

Towner JS, Paragas J, Dover JE, Gupta M, Goldsmith CS, Huggins JW, Nichol ST.

Virology. 2005 Feb 5;332(1):20-7.

18.

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.

Gibb TR, Bray M, Geisbert TW, Steele KE, Kell WM, Davis KJ, Jaax NK.

J Comp Pathol. 2001 Nov;125(4):233-42.

PMID:
11798240
19.

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Mahanty S, Gupta M, Paragas J, Bray M, Ahmed R, Rollin PE.

Virology. 2003 Aug 1;312(2):415-24.

20.

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.

Bray M, Geisbert TW.

Int J Biochem Cell Biol. 2005 Aug;37(8):1560-6. Epub 2005 Mar 7.

PMID:
15896665
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk